Relmada Therapeutics, Inc.
RLMD
$0.5904
-$0.032-5.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.06M | 44.91M | 54.12M | 70.44M | 83.61M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 596.40K | 886.50K | 1.58M | 537.50K | 752.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 27.66M | 45.80M | 55.70M | 70.97M | 84.37M |
|
|
|||||
| Total Current Assets | 27.66M | 45.80M | 55.70M | 70.97M | 84.37M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.00K | 22.00K | 22.00K | 53.60K | 43.10K |
| Total Assets | 27.68M | 45.82M | 55.72M | 71.03M | 84.41M |
|
|
|||||
| Total Accounts Payable | 1.27M | 4.13M | 2.35M | 4.17M | 5.19M |
| Total Accrued Expenses | 3.97M | 6.16M | 5.74M | 5.36M | 7.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.23M | 10.29M | 8.09M | 9.54M | 12.36M |
|
|
|||||
| Total Current Liabilities | 5.23M | 10.29M | 8.09M | 9.54M | 12.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.50K | 4.50K | 12.60K | -- | -- |
| Total Liabilities | 5.24M | 10.30M | 8.10M | 9.54M | 12.36M |
|
|
|||||
| Common Stock & APIC | 680.88M | 676.40M | 669.85M | 661.99M | 654.78M |
| Retained Earnings | -658.44M | -640.88M | -622.22M | -600.50M | -582.73M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 22.44M | 35.52M | 47.63M | 61.49M | 72.05M |
|
|
|||||